Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imaging Diagnostics Systems - IMDS -- Ignore unavailable to you. Want to Upgrade?

To: Scott Phillips who wrote (8)	12/27/1998 9:58:00 PM
From: chirodoc	Respond to of 9

Imaging Diagnostic Systems Unveils In-Vivo Images At The 84th Radiological Society Of North America Conference PR Newswire - December 02, 1998 08:17 FORT LAUDERDALE, Fla., Dec. 2 /PRNewswire/ -- Imaging Diagnostic Systems Inc. (OTC Bulletin Board: IMDS) sent out a clear message today at the 84th annual Radiological Society of North America medical conference in Chicago with a vivid display of twenty comparative in-vivo images as evidence of the Company's progress toward refining its proprietary CT Laser Breast Imaging System. According to the Company, the images demonstrated the ability of the proprietary reconstruction algorithms to reveal the inner structures of the breast. "With major enhancements to our lasers and technology we're now able to see distinguishable tissue differentiation and produce consistent clinical-quality images," said Richard Grable, CEO and CTLM(TM) inventor. The Company recently announced that they have completed the first phase of clinical testing and will submit this data to the FDA to keep them apprised of their progress. Nassau County Medical Center will be the first site for this next phase of testing. It also happens to be an area of the country where breast cancer rates are among the highest in the nation. Imaging Diagnostic Systems has developed a non-invasive procedure using high-speed lasers and CT-type reconstruction technology to detect breast abnormalities. Forward-looking statements in this release are made pursant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties, including without limitation, the Company's ability to successfully complete and file a PMA application; the status of competing products; and uncertainties detailed in the Company's Form 10-KSB filed August 20, 1996 with the Securities and Exchange Commission. SOURCE Imaging Diagnostic Systems Inc.